A Novel Nanomedicine System TAR-AuNSs/Dox for the Treatment of Drug-Resistant Lymphoma

Figure 8

Biocompatibility of TAR-AuNSs/Dox on drug-resistant tumor-bearing mice. (a) Hematological and hematobiochemical indexes of mice at the 18th day with PBS, Dox, AuNSs/Dox, and TAR-AuNSs/Dox, respectively. (b) Hematoxylin and eosin (H&E) staining images of the lung, liver, spleen, kidney, and heart of mice at the 18th day with PBS, Dox, AuNSs/Dox, and TAR-AuNSs/Dox, respectively.

(a)

(b)